Ovarian germ cell cancer: Clinicopathologic analysis and outcome of 31 cases

dc.creatorKusamura, S
dc.creatorTeixeira, LC
dc.creatordos Santos, MA
dc.creatorAndrade, LALD
dc.creatorTorres, JCC
dc.creatorSagarra, A
dc.creatorDeraco, M
dc.creatorDerchain, SFM
dc.date2000
dc.dateNOV-DEC
dc.date2014-08-01T18:37:00Z
dc.date2015-11-26T18:05:07Z
dc.date2014-08-01T18:37:00Z
dc.date2015-11-26T18:05:07Z
dc.date.accessioned2018-03-29T00:47:24Z
dc.date.available2018-03-29T00:47:24Z
dc.identifierTumori. Pensiero Scientifico Editor, v. 86, n. 6, n. 450, n. 454, 2000.
dc.identifier0300-8916
dc.identifierWOS:000166686800003
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/81524
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/81524
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1293051
dc.descriptionAims: The aim of the study was to evaluate some clinicopathologic characteristics and the outcome of patients with ovarian germ cell cancer (OGCC) treated with cisplatin-based chemotherapy. Methods: It was a clinical retrospective study. The clinical charts of 31 patients with OGCC assisted at the Department of Obstetrics and Gynecology of the State University of Campinas, Brazil, from January 1986 to June 1997 were reviewed. Results: Ten patients had dysgerminoma and 21 patients nondysgerminomatous tumors. Women with dysgerminoma and nondysgerminomatous tumors did not present differences regarding surgical staging, age, ascites or residual tumor after the Initial surgery. Frozen section, performed in 16 patients, showed some discrepancy with paraffin histology diagnosis in 8 patients. Platinum-based chemotherapy was used in 5/10 patients with dysgerminoma and in 17/21 patients with nondysgerminomatous tumors, with a 5-year survival of 100% for the dysgerminoma and 53% for the nondysgerminomatous group. Conclusions: women with dysgerminoma and nondysgerminomatous tumors did not present differences regarding clinicopathologic characteristics. The prognosis for patients with dysgerminoma was better than for those with nondysgerminomatous tumors. Frozen section had a high error rate in diagnosing OGCC intraoperatively.
dc.description86
dc.description6
dc.description450
dc.description454
dc.languageen
dc.publisherPensiero Scientifico Editor
dc.publisherRome
dc.publisherItália
dc.relationTumori
dc.relationTumori
dc.rightsfechado
dc.sourceWeb of Science
dc.subjectcisplatin-based chemotherapy
dc.subjectfrozen section
dc.subjectgerm cells ovarian cancer
dc.subjectsurgery
dc.subjectGynecologic-oncology-group
dc.subjectCisplatin-based Chemotherapy
dc.subjectInstitut-gustave-roussy
dc.subject2nd-look Laparotomy
dc.subjectTumors
dc.subjectExperience
dc.subjectDysgerminoma
dc.subjectManagement
dc.subjectBleomycin
dc.subjectVinblastine
dc.titleOvarian germ cell cancer: Clinicopathologic analysis and outcome of 31 cases
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución